BackAcelyrin Overview

Acelyrin Receivables

Latest receivables for SLRN: $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-5.36M vs prior year quarter

Peer trimmed avg / median

Loading

Acelyrin Receivables History

Loading

Acelyrin vs. peers: Receivables Comparison

Loading

Acelyrin Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Acelyrin (SLRN) FAQ

Acelyrin (SLRN) currently reports a receivables of $0 as of March 2025. That compares with $5.4M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Acelyrin's receivables history and peer comparisons.

Acelyrin's receivables decreased from $5.4M to $0 — a 100.0% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelyrin reported $0 in receivables as of March 2025. That compares with $5.4M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.